Can combined biomarker testing shape the future of primary care antibiotic prescribing?
Carl Llor, Niels Kristian Kjær · 2026
Read Can combined biomarker testing shape the future of primary care antibiotic prescribing? by Carl Llor, Niels Kristian Kjær (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13279759.txt.
Description
Carl Llor and Niels Kristian Kjaer write a 2026 commentary on combined biomarker testing in primary care. Antibiotic overuse is a top world health worry, most in chest infections seen in family care. Most such infections are viral and self limited, yet antibiotics flow at high rates. One nation example looms large: China uses about one fourth of all human antibiotics in the world.
In Chinese primary care, more than half of cold type visits end with antibiotics, and many patients get more than one drug. For bronchitis, the rate nears seventy percent, though antibiotics do not cut grave side effects there. Overuse feeds antimicrobial resistance, where germs beat drugs. The pair ask if paired biomarker tests, which flag bacterial infection, can steer doctors to prescribe less. Sound point of care tests could cut waste while keeping patients safe.
Catalog record
| CREATOR | Carl Llor, Niels Kristian Kjær |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 6173 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |